Loading...

Janus Henderson Global Life Sciences Fund Class C

JFNCXNASDAQ
Financial Services
Asset Management - Global
$55.47
$0.31(0.56%)

Janus Henderson Global Life Sciences Fund Class C JFNCX Peers

See (JFNCX) competitors and their performances in Stock Market.

Peer Comparison Table: Asset Management - Global Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
JFNCX$55.47+0.56%4.4BN/AN/AN/A
APO$142.05+0.13%80.9B24.67$5.74+1.34%
FESGX$73.50+1.06%60.9B18.46$3.96N/A
SGENX$77.29+1.07%60.8B18.49$4.16N/A
FEGRX$77.88+1.08%60.3B18.49$4.19N/A
SGIIX$77.83+1.06%60.3B18.49$4.19N/A
APO-PA$75.26+0.55%43B9.04$8.32+1.34%
GBLEX$39.69+0.33%27.3B20.56$1.93N/A
AGVEX$26.25+0.08%16.9B26.35$1.00N/A
MDLOX$20.49-0.15%16.9BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

JFNCX vs APO Comparison

JFNCX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, JFNCX stands at 4.4B. In comparison, APO has a market cap of 80.9B. Regarding current trading prices, JFNCX is priced at $55.47, while APO trades at $142.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

JFNCX currently has a P/E ratio of N/A, whereas APO's P/E ratio is 24.67. In terms of profitability, JFNCX's ROE is N/A, compared to APO's ROE of +0.21%. Regarding short-term risk, JFNCX is less volatile compared to APO. This indicates potentially lower risk in terms of short-term price fluctuations for JFNCX.

Stock Price Comparison

Loading...

Frequently Asked Questions

;